ROC-话题@MedSci

#ROC#

194篇内容 | 3743人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1977046, encodeId=bda519e704601, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Ann Oncol：III期BROCADE3研究表明Veliparib（维利帕尼）联合卡铂/紫杉醇后Veliparib维持治疗可改善BRCA1/2生殖系突变乳腺癌患者的疗效, objectType=article, longId=295703, objectId=ea9c295e0337, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea9c295e0337, replyNumber=0, likeNumber=98, createdTime=2022-07-27, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea9c295e0337, moduleTitle=Ann Oncol：III期BROCADE3研究表明Veliparib（维利帕尼）联合卡铂/紫杉醇后Veliparib维持治疗可改善BRCA1/2生殖系突变乳腺癌患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea9c295e0337)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977050, encodeId=a0b219e705022, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=ICER评估Roctavian和EtranaDez基因疗法治疗A型和B型血友病, objectType=article, longId=726366, objectId=421ee263669d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=421ee263669d, replyNumber=0, likeNumber=115, createdTime=2023-04-09, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=421ee263669d, moduleTitle=ICER评估Roctavian和EtranaDez基因疗法治疗A型和B型血友病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=421ee263669d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977044, encodeId=fa3819e7044e9, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Mayo Clin Proc：骨质疏松症及其与心血管疾病，呼吸系统疾病和癌症的关系, objectType=article, longId=294729, objectId=f679294e29e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f679294e29e1, replyNumber=0, likeNumber=98, createdTime=2022-12-24, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f679294e29e1, moduleTitle=Mayo Clin Proc：骨质疏松症及其与心血管疾病，呼吸系统疾病和癌症的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f679294e29e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977043, encodeId=845b19e704397, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=European Radiology：FROC模型和双参数VI-RADS对膀胱尿路上皮癌分期和分级的评价, objectType=article, longId=293825, objectId=89ce2938257f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89ce2938257f, replyNumber=0, likeNumber=84, createdTime=2022-10-13, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89ce2938257f, moduleTitle=European Radiology：FROC模型和双参数VI-RADS对膀胱尿路上皮癌分期和分级的评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89ce2938257f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977047, encodeId=5dc719e704712, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Mayo Clin Proc：单克隆抗体在预防出现德尔塔亚型的严重COVID-19中的有效性, objectType=article, longId=299885, objectId=dbcf299885c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbcf299885c7, replyNumber=0, likeNumber=90, createdTime=2022-06-01, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbcf299885c7, moduleTitle=Mayo Clin Proc：单克隆抗体在预防出现德尔塔亚型的严重COVID-19中的有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbcf299885c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977048, encodeId=838219e704846, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Mayo Clin Proc：系统性红斑狼疮和抗磷脂抗体综合征患者发生生物瓣膜血栓的极端病例, objectType=article, longId=300410, objectId=2b63300410f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b63300410f8, replyNumber=0, likeNumber=97, createdTime=2022-12-17, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b63300410f8, moduleTitle=Mayo Clin Proc：系统性红斑狼疮和抗磷脂抗体综合征患者发生生物瓣膜血栓的极端病例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b63300410f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977042, encodeId=6ebd19e70426d, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Mayo Clin Proc：糖皮质激素的使用会增加患带状疱疹风险吗？, objectType=article, longId=220803, objectId=7a6c22080334, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a6c22080334, replyNumber=0, likeNumber=104, createdTime=2022-07-10, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a6c22080334, moduleTitle=Mayo Clin Proc：糖皮质激素的使用会增加患带状疱疹风险吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a6c22080334)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977049, encodeId=968819e70492d, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Mayo Clin Proc：成人慢性阻塞性肺疾病心肌梗死后心脏选择性与非选择性β受体阻滞剂的比较, objectType=article, longId=300307, objectId=bf2730030e4f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf2730030e4f, replyNumber=0, likeNumber=116, createdTime=2023-02-07, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf2730030e4f, moduleTitle=Mayo Clin Proc：成人慢性阻塞性肺疾病心肌梗死后心脏选择性与非选择性β受体阻滞剂的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf2730030e4f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977045, encodeId=35cd19e704549, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=罗氏 (Roche) 的双特异性Vabysmo获得FDA批准用于湿性AMD、糖尿病性黄斑水肿, objectType=article, longId=295101, objectId=9181295101bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9181295101bf, replyNumber=0, likeNumber=113, createdTime=2023-01-01, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9181295101bf, moduleTitle=罗氏 (Roche) 的双特异性Vabysmo获得FDA批准用于湿性AMD、糖尿病性黄斑水肿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9181295101bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977038, encodeId=8e9a19e7038d4, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Proc Natl Acad Sci ：为什么在听到响亮的声音后短暂失去了听力？, objectType=article, longId=214101, objectId=15522141014d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15522141014d, replyNumber=0, likeNumber=94, createdTime=2021-11-24, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15522141014d, moduleTitle=Proc Natl Acad Sci ：为什么在听到响亮的声音后短暂失去了听力？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15522141014d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977037, encodeId=b6f019e703701, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=时间依赖性ROC曲线及R语言实现, objectType=article, longId=212996, objectId=32f12129967a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32f12129967a, replyNumber=0, likeNumber=111, createdTime=2021-08-26, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32f12129967a, moduleTitle=时间依赖性ROC曲线及R语言实现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32f12129967a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977041, encodeId=fdfd19e70415b, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Mayo Clin Proc：富含血小板血浆对慢性伤口愈合的疗效和安全性, objectType=article, longId=218972, objectId=9fd42189e2f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fd42189e2f2, replyNumber=0, likeNumber=106, createdTime=2022-09-26, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fd42189e2f2, moduleTitle=Mayo Clin Proc：富含血小板血浆对慢性伤口愈合的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fd42189e2f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977040, encodeId=5c8a19e7040ed, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Abrocitinib获得CHMP的积极意见，用于治疗成人中重度特应性皮炎, objectType=article, longId=218693, objectId=91f621869309, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91f621869309, replyNumber=0, likeNumber=85, createdTime=2022-07-06, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91f621869309, moduleTitle=Abrocitinib获得CHMP的积极意见，用于治疗成人中重度特应性皮炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91f621869309)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977036, encodeId=c98719e70362e, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Brain：语言表达中枢还只知道Broca区？你out了！, objectType=article, longId=210566, objectId=71a021056660, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71a021056660, replyNumber=0, likeNumber=125, createdTime=2021-12-25, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71a021056660, moduleTitle=Brain：语言表达中枢还只知道Broca区？你out了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71a021056660)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977034, encodeId=429419e70344e, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=J Neurochem:脑血流连通性可作为皮质下卒中影像预后生物标志物, objectType=article, longId=209256, objectId=05012092564a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05012092564a, replyNumber=0, likeNumber=95, createdTime=2021-10-11, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05012092564a, moduleTitle=J Neurochem:脑血流连通性可作为皮质下卒中影像预后生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05012092564a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977033, encodeId=1a6519e703300, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=NEJM：口服JAK抑制剂abroctinib用于中重度特应性皮炎, objectType=article, longId=209011, objectId=43102090117d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43102090117d, replyNumber=0, likeNumber=109, createdTime=2021-07-06, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43102090117d, moduleTitle=NEJM：口服JAK抑制剂abroctinib用于中重度特应性皮炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43102090117d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977039, encodeId=55a819e70398c, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Allergy Asthma Proc：哮喘和鼻炎控制对工作效率和活动障碍的交互影响, objectType=article, longId=214745, objectId=686f214e45dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=686f214e45dc, replyNumber=0, likeNumber=116, createdTime=2022-02-16, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=686f214e45dc, moduleTitle=Allergy Asthma Proc：哮喘和鼻炎控制对工作效率和活动障碍的交互影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=686f214e45dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977030, encodeId=4b3419e7030fb, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=Abrocitinib治疗中重度特应性皮炎的III期研究：已达到主要终点, objectType=article, longId=203284, objectId=ffda20328428, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ffda20328428, replyNumber=0, likeNumber=89, createdTime=2021-06-12, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ffda20328428, moduleTitle=Abrocitinib治疗中重度特应性皮炎的III期研究：已达到主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ffda20328428)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977035, encodeId=481819e70352f, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=J Clin Oncol：ROCK2抑制剂贝鲁地尔可有效治疗难治性慢性移植物抗宿主病, objectType=article, longId=210383, objectId=687e210383ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=687e210383ae, replyNumber=0, likeNumber=101, createdTime=2022-02-25, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=687e210383ae, moduleTitle=J Clin Oncol：ROCK2抑制剂贝鲁地尔可有效治疗难治性慢性移植物抗宿主病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=687e210383ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1977031, encodeId=edbe19e7031e6, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, objectTitle=NICE将新型抗生素Fetcroja（cefiderocol）纳入试点报销范围, objectType=article, longId=205044, objectId=c2e52050447d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2e52050447d, replyNumber=0, likeNumber=100, createdTime=2021-12-06, rootId=0, userName=linlin2312, userId=d590125, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2e52050447d, moduleTitle=NICE将新型抗生素Fetcroja（cefiderocol）纳入试点报销范围, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2e52050447d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ROC

2020-05-29

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Ann Oncol：III期BROCADE3研究表明Veliparib（维利帕尼）联合卡铂/紫杉醇后Veliparib维持治疗可改善BRCA1/2生殖系突变乳腺癌患者的疗效

2022-07-27

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

ICER评估Roctavian和EtranaDez基因疗法治疗A型和B型血友病

2023-04-09

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Mayo Clin Proc：骨质疏松症及其与心血管疾病，呼吸系统疾病和癌症的关系

2022-12-24

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

European Radiology：FROC模型和双参数VI-RADS对膀胱尿路上皮癌分期和分级的评价

2022-10-13

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Mayo Clin Proc：单克隆抗体在预防出现德尔塔亚型的严重COVID-19中的有效性

2022-06-01

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Mayo Clin Proc：系统性红斑狼疮和抗磷脂抗体综合征患者发生生物瓣膜血栓的极端病例

2022-12-17

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Mayo Clin Proc：糖皮质激素的使用会增加患带状疱疹风险吗？

2022-07-10

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Mayo Clin Proc：成人慢性阻塞性肺疾病心肌梗死后心脏选择性与非选择性β受体阻滞剂的比较

2023-02-07

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

罗氏 (Roche) 的双特异性Vabysmo获得FDA批准用于湿性AMD、糖尿病性黄斑水肿

2023-01-01

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Proc Natl Acad Sci ：为什么在听到响亮的声音后短暂失去了听力？

2021-11-24

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

时间依赖性ROC曲线及R语言实现

2021-08-26

heli0118 (审核中...)

前往app查看评论内容

#ROC#

Mayo Clin Proc：富含血小板血浆对慢性伤口愈合的疗效和安全性

2022-09-26

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Abrocitinib获得CHMP的积极意见，用于治疗成人中重度特应性皮炎

2022-07-06

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Brain：语言表达中枢还只知道Broca区？你out了！

2021-12-25

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

J Neurochem:脑血流连通性可作为皮质下卒中影像预后生物标志物

2021-10-11

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

NEJM：口服JAK抑制剂abroctinib用于中重度特应性皮炎

2021-07-06

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Allergy Asthma Proc：哮喘和鼻炎控制对工作效率和活动障碍的交互影响

2022-02-16

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

Abrocitinib治疗中重度特应性皮炎的III期研究：已达到主要终点

2021-06-12

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

J Clin Oncol：ROCK2抑制剂贝鲁地尔可有效治疗难治性慢性移植物抗宿主病

2022-02-25

linlin2312 (审核中...)

前往app查看评论内容

#ROC#

NICE将新型抗生素Fetcroja（cefiderocol）纳入试点报销范围

2021-12-06

科室
- - 订阅+
  - 更多科室
工具
服务